As it prepares to launch a commercial product early next year, Lumera last week carved out its biosciences division into a separate subsidiary to eliminate any confusion about its proteomics business.
 
The new company, called Plexera Bioscience, will now focus on further developing its main proteomics platform, the ProteomicProcessor Biosensor, to bring to market.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.